Anika Therapeutics (ANIK) Divestments (2025)

Anika Therapeutics' (ANIK) quarterly Divestments came in at $4.5 million in Q1 2025.

Anika Therapeutics (ANIK) Divestments (2025) Analysis & Trends

Anika Therapeutics (ANIK) has 1 years of Divestments data on file, last reported at $4.5 million in Q1 2025.

  • On a quarterly basis, Divestments changed N/A year-over-year to $4.5 million in Q1 2025; TTM through Dec 2025 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.5 million, changed N/A from the prior year.
  • Divestments for Q1 2025 stood at $4.5 million.
  • Over the last five years, Divestments for ANIK reached as high as $4.5 million in Q1 2025 and fell as low as $4.5 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 42.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.28 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 63.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Anika Therapeutics 198.50 Mn 131.71 Mn 19.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 4.50 Mn